Baird Downgrades Aprea (APRE) to Neutral on Trial Failure

Go back to Baird Downgrades Aprea (APRE) to Neutral on Trial Failure

UPDATE: RBC Capital Downgrades Aprea (APRE) to Sector Perform on Trial Failure

December 28, 2020 11:56 AM EST

(Updated - December 29, 2020 4:57 AM EST)

(updating comment)

RBC Capital analyst Gregory Renza downgraded Aprea (NASDAQ: APRE) from Outperform to Sector Perform with a price target of $10.00 (from $40.00).

The analyst comments "This morning, APRE reported topline of the... More